Claro Advisors LLC Amgen Inc Transaction History

Claro Advisors LLC

$706 Million
Q3 2024

A detailed history of Claro Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Claro Advisors LLC holds 4,912 shares of AMGN stock, worth $1.38 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

4,912

Previous 4,906 0.12%

Holding current value

$1.38 Million

Previous $1.58 Million 0.13%

% of portfolio

0.22%

Previous 0.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$309.38 - $337.38 $1,856 - $2,024	6 Added 0.12%	4,912 $1.58 Million
Q3 2024 Oct 17, 2024	BUY	$309.38 - $337.38 $66,826 - $72,874	216 Added 4.61%	4,906 $1.58 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $262 - $319	-1 Reduced 0.02%	4,690 $1.47 Million
Q1 2024 Apr 18, 2024	BUY	$268.87 - $324.56 $684,274 - $826,005	2,545 Added 118.59%	4,691 $1.33 Million
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $96,143 - $108,460	-376 Reduced 14.91%	2,146 $618,000
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $142,997 - $177,534	654 Added 35.01%	2,522 $677,000
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $25,712 - $30,404	120 Added 6.86%	1,868 $414,000
Q1 2023 Apr 17, 2023	BUY	$225.79 - $275.2 $26,869 - $32,748	119 Added 7.31%	1,748 $422,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $51,073 - $64,895	223 Added 15.86%	1,629 $427,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $7,152 - $7,958	31 Added 2.25%	1,406 $342,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $62,647 - $71,694	315 Added 29.72%	1,375 $309,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $212 - $248	1 Added 0.09%	1,060 $225,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $7,007 - $7,774	30 Added 2.92%	1,059 $258,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $7,766 - $9,051	-35 Reduced 3.29%	1,029 $256,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $14,281 - $17,006	-66 Reduced 5.84%	1,064 $245,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1,877 - $2,087	-8 Reduced 0.7%	1,130 $287,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $10,681 - $13,107	54 Added 4.98%	1,138 $269,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $5,649 - $7,492	31 Added 2.94%	1,084 $220,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $2,459 - $3,161	13 Added 1.25%	1,053 $254,000
Q3 2019 Oct 29, 2019	BUY	$174.11 - $208.62 $181,074 - $216,964	1,040 New	1,040 $201,000
Q2 2019 Jul 24, 2019	SELL	$166.7 - $195.41 $209,875 - $246,021	-1,259 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $42,323 - $47,707	234 Added 22.83%	1,259 $239,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $182,860 - $213,456	1,025 New	1,025 $213,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.

Account

Claro Advisors LLC Amgen Inc Transaction History